CLARITY PHARMA RESEARCH ®
PHARMACEUTICAL MARKET RESEARCH REPORTS BASED IN SCIENCE ™

A sample drawn by the previous supplier of a Hep C study conducted for a large pharmaceutical company in the US was made up of only 14% non-Caucasians. According to the CDC, non-Caucasians made up 35% of the Hep C cases of chronic HCV in the US in 2000. Thus, the previous supplier’s study was drawn from an incorrect sample.
Both of our subsequent studies were composed of a representative sample that included the correct proportions.

Hep C Study Shows Why Sampling Matters

Our respondents mirrored actual US patient universe

© 2014-2023 Clarity Pharma Research® LLC | All Rights Reserved | Privacy Policy
To learn more about our services, contact information@claritypharma.com.